Harwood Feffer LLP

NEW YORK, March 19, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI), concerning whether the board has breached its fiduciary duties to shareholders. (Logo: http://photos.prnewswire.com/prnh/20120215/MM54604LOGO ) On March 12, 2013, ... read more

NEW YORK, Jan. 24, 2013 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of MAP Pharmaceuticals, Inc. ("MAP" or the "Company") (NASDAQ: MAPP) concerning the proposed acquisition of the Company by Allergan, Inc. ("Allergan") in a transaction valued at approximately ... read more

NEW YORK, Dec. 28, 2012 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of BCD Semiconductor Manufacturing Ltd. ("BCD" or the "Company") (NASDAQ: BCDS) concerning the proposed acquisition of the Company by Diodes Inc. ("Diodes") in a transaction valued at ... read more